R-HSA-111885
|
Opioid Signalling
|
R-HSA-111932
|
CaMK IV-mediated phosphorylation of CREB
|
R-HSA-111933
|
Calmodulin induced events
|
R-HSA-111996
|
Ca-dependent events
|
R-HSA-111997
|
CaM pathway
|
R-HSA-112040
|
G-protein mediated events
|
R-HSA-112043
|
PLC beta mediated events
|
R-HSA-112314
|
Neurotransmitter receptors and postsynaptic signal transmission
|
R-HSA-112314
|
Neurotransmitter receptors and postsynaptic signal transmission
|
R-HSA-112315
|
Transmission across Chemical Synapses
|
R-HSA-112315
|
Transmission across Chemical Synapses
|
R-HSA-112316
|
Neuronal System
|
R-HSA-112316
|
Neuronal System
|
R-HSA-1280215
|
Cytokine Signaling in Immune system
|
R-HSA-1489509
|
DAG and IP3 signaling
|
R-HSA-162582
|
Signal Transduction
|
R-HSA-162582
|
Signal Transduction
|
R-HSA-1643685
|
Disease
|
R-HSA-168256
|
Immune System
|
R-HSA-212436
|
Generic Transcription Pathway
|
R-HSA-2262752
|
Cellular responses to stress
|
R-HSA-3371556
|
Cellular response to heat stress
|
R-HSA-3371571
|
HSF1-dependent transactivation
|
R-HSA-372790
|
Signaling by GPCR
|
R-HSA-382551
|
Transport of small molecules
|
R-HSA-388396
|
GPCR downstream signalling
|
R-HSA-397014
|
Muscle contraction
|
R-HSA-399719
|
Trafficking of AMPA receptors
|
R-HSA-399721
|
Glutamate binding, activation of AMPA receptors and synaptic plasticity
|
R-HSA-418594
|
G alpha (i) signalling events
|
R-HSA-438064
|
Post NMDA receptor activation events
|
R-HSA-438066
|
Unblocking of NMDA receptors, glutamate binding and activation
|
R-HSA-438066
|
Unblocking of NMDA receptors, glutamate binding and activation
|
R-HSA-442729
|
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
|
R-HSA-442742
|
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling
|
R-HSA-442755
|
Activation of NMDA receptors and postsynaptic events
|
R-HSA-442755
|
Activation of NMDA receptors and postsynaptic events
|
R-HSA-442982
|
Ras activation upon Ca2+ influx through NMDA receptor
|
R-HSA-449147
|
Signaling by Interleukins
|
R-HSA-449836
|
Other interleukin signaling
|
R-HSA-5576891
|
Cardiac conduction
|
R-HSA-5576892
|
Phase 0 - rapid depolarisation
|
R-HSA-5578775
|
Ion homeostasis
|
R-HSA-5663202
|
Diseases of signal transduction
|
R-HSA-5673000
|
RAF activation
|
R-HSA-5673001
|
RAF/MAP kinase cascade
|
R-HSA-5683057
|
MAPK family signaling cascades
|
R-HSA-5684996
|
MAPK1/MAPK3 signaling
|
R-HSA-6802946
|
Signaling by moderate kinase activity BRAF mutants
|
R-HSA-6802949
|
Signaling by RAS mutants
|
R-HSA-6802952
|
Signaling by BRAF and RAF fusions
|
R-HSA-6802955
|
Paradoxical activation of RAF signaling by kinase inactive BRAF
|
R-HSA-6802957
|
Oncogenic MAPK signaling
|
R-HSA-73857
|
RNA Polymerase II Transcription
|
R-HSA-74160
|
Gene expression (Transcription)
|
R-HSA-877300
|
Interferon gamma signaling
|
R-HSA-8953897
|
Cellular responses to external stimuli
|
R-HSA-8986944
|
Transcriptional Regulation by MECP2
|
R-HSA-9006925
|
Intracellular signaling by second messengers
|
R-HSA-9022692
|
Regulation of MECP2 expression and activity
|
R-HSA-913531
|
Interferon Signaling
|
R-HSA-936837
|
Ion transport by P-type ATPases
|
R-HSA-9607240
|
FLT3 Signaling
|
R-HSA-9609736
|
Assembly and cell surface presentation of NMDA receptors
|
R-HSA-9617324
|
Negative regulation of NMDA receptor-mediated neuronal transmission
|
R-HSA-9620244
|
Long-term potentiation
|
R-HSA-983712
|
Ion channel transport
|